|
Alfred Botchway, Ph.D. is Founder and President of Xenometrics. Dr Botchway has numerous years of experience spanning academic research, a major pharmaceutical company and a contract laboratory. His experience includes extensive research in safety pharmacology, and Alfred has monitored and conducted numerous studies on behalf of large pharmaceutical companies. Dr. Botchway has authored scholarly articles (with international circulation), and been profoundly involved with studies in support of INDs. Furthermore, he has served as a reviewer for multiple scientific manuscripts for highly esteemed international scientific journals. In addition to membership of several international scholastic professional scientific organizations, Alfred is an active member of the Safety Pharmacology Society. Dr. Botchway was awarded his Ph.D. in Cardiovascular Physiology at Imperial College of Science, Technology and Medicine, University of London, UK.
Tom Haymaker, BS is Co-Founder and Director of Operations of Xenometrics. Mr Haymaker adds over 12 years of experience in various facets of research to the team. Subsequent to graduating from Kansas State University, Tom gained a vast amount of experience during his time of service at several research organizations. He has been instrumental in designing, coordination, conducting and reporting of non-clinical pharmacokinetic studies required for evaluating a drug’s potential bioavailability. Tom has worked in collaboration with a diverse spectrum of companies.
Sandra Love, Ph.D. is Director of Pharmacology services at Xenometrics. Dr Love oversees the company's safety and exploratory pharmacology services. She has more than 15 years of experience in pharmaceutical research and pre-clinical development of new molecular entities for IND submissions. Dr Love began her career as a research pharmacologist at Marion Laboratories and Marion Merrell Dow. She has held senior positions, including head of cardiac electrophysiology and in-vitro pharmacology at a contract research organization. Dr Love brings a wealth of experience and leadership to Xenometrics.
Devendra Dandekar, Ph.D. is Director of Toxicology services at Xenometrics. Dr Dandekar is responsible for the company’s nonclinical Toxicology services working with a wide range of biotechnology and pharmaceutical companies. Dr Dandekar has more than 10 years of research experience in spanning both academia and industry. Dr Dandekar holds a BS, MS, and a Ph.D. in Zoology from the Maharaja Sayajirao University of Baroda, India.
The management team and scientific staff hold memberships to several internationally recognized professional scientific organizations, including:
Joel Laner, BA, LLM is general counsel for Xenometrics. Laner has continuously practiced law for nearly 25 years in the business and real estate areas. His practice encompasses corporate, tax, and securities law. Laner has represented companies involved in a wide range of business activities including mergers, tax-free reorganizations, spin-offs, sales, work-outs, refinancings, public and private issues, consolidations, and joint ventures. Laner has handled employment agreements, deferred compensation arrangements, stock purchase and phantom stock plans, business formations and liquidations, and franchising and licensing arrangements.
The private organization, Xenometrics LLC., sets out on a mission to serve the Pharmaceutical Industry in its capacity of conducting high quality research. The current personnel, facilities and equipment are primed to meet your outsourcing needs. The breadth of companies we serve include Biotech, Pharmaceutical, Medical device research, and animal health industry. We would be pleased to provide you with references if required.
Quality at Xenometrics
Our data review process includes detailed quality control steps which ensure that your data is of the highest quality.
We have a dedicated Quality Assurance consulting company (QA Compliant, Inc.) located on the research park who maintains a strong presence within Xenometrics providing process monitoring, facility inspections, in-lab inspections, protocol/data/report audits, computer system validation review, SOP review and GLP Training. This Quality Assurance Consulting Company is a separately operated company, serving as Xenometrics Quality Assurance Unit, and is committed to ensuring compliance of Standard Operating Procedures and worldwide regulations including the following:
• US FDA 21 CFR Part 58 Good Laboratory Practices for nonclinical Laboratory Studies
• US EPA 40 CFR Part 160 Federal Insecticide, Fungicide, and Rodenti-cide Act (FIFRA) Good Laboratory Practice Standards
• US EPA 40 CFR Part 792 Toxic Substances Control Act (TSCA): Good Laboratory Practice Standards
• Organization for Economic Co-operation and Development (OECD) Principles on Good Laboratory Practices
• Japanese Ministry of Health, Labour and Welfare (MHLW) Good Laboratory Practice Standards Ordinance No. 21
Study Sponsor and potential Client visits are welcome. To schedule a visit please contact either QA Compliant or Xenometrics
|
|
|
|
|
|